ETC
JAZZ icon

Exchange Traded Concepts’s Jazz Pharmaceuticals JAZZ Stock Holding History

Exchange Traded Concepts’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
938
+133
+17% +$29.1K ﹤0.01% 1350
2026
Q1 		$152K Sell
805
-328
-29% -$57.3K ﹤0.01% 1288
2025
Q4 		$193K Buy
+1,133
New +$174K ﹤0.01% 1258
2025
Q3 		– Sell
-5,914
Closed -$628K – 1495
2025
Q2 		$628K Buy
5,914
+112
+2% +$12.2K 0.01% 861
2025
Q1 		$720K Sell
5,802
-1,243
-18% -$162K 0.01% 712
2024
Q4 		$868K Buy
7,045
+155
+2% +$18.3K 0.02% 619
2024
Q3 		$768K Buy
6,890
+1,233
+22% +$135K 0.02% 641
2024
Q2 		$604K Buy
5,657
+283
+5% +$31.1K 0.02% 645
2024
Q1 		$647K Buy
5,374
+770
+17% +$94.3K 0.02% 573
2023
Q4 		$566K Hold
4,604
– – 0.02% 585
2023
Q3 		$596K Buy
4,604
+284
+7% +$37.8K 0.02% 523
2023
Q2 		$536K Buy
4,320
+70
+2% +$9.42K 0.01% 595
2023
Q1 		$622K Sell
4,250
-826
-16% -$122K 0.02% 481
2022
Q4 		$809K Buy
5,076
+286
+6% +$41.9K 0.02% 334
2022
Q3 		$638K Buy
4,790
+4
+0.1% +$608 0.02% 344
2022
Q2 		$747K Buy
4,786
+402
+9% +$61.9K 0.02% 338
2022
Q1 		$682K Buy
4,384
+399
+10% +$57.9K 0.01% 420
2021
Q4 		$508K Sell
3,985
-233
-6% -$30.6K 0.01% 676
2021
Q3 		$549K Buy
4,218
+917
+28% +$139K 0.01% 508
2021
Q2 		$586K Buy
3,301
+129
+4% +$22.3K 0.02% 468
2021
Q1 		$521K Buy
3,172
+2,962
+1,410% +$487K 0.02% 448
2020
Q4 		$35K Buy
+210
New +$31.3K ﹤0.01% 775

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Exchange Traded Concepts's JAZZ Position: Q2 2026 in Review

Exchange Traded Concepts increased its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q2 2026, buying an estimated $29.1K and bringing the position to 938 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Exchange Traded Concepts first reported a position in JAZZ in Q4 2020 and has held it in 22 quarters since. The position peaked at $868K in Q4 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Exchange Traded Concepts held 938 shares of Jazz Pharmaceuticals worth $226K as of Q2 2026.
  • Exchange Traded Concepts bought 133 Jazz Pharmaceuticals shares in Q2 2026, an estimated $29.1K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1350 holding.
  • Exchange Traded Concepts first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Exchange Traded Concepts's Jazz Pharmaceuticals position peaked at $868K in Q4 2024.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.